Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)-Reference-Cited by-同舟云学术

Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS)

Published:2009-06-17 Issue:4 Volume:28 Page:489-495
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Andreotti Felicita,Agati Luciano,Conti Elena,Santucci Eleonora,Rio Teresa,Tarantino Federica,Natale Luigi,Berardi Daniele,Mattatelli Antonella,Musumeci Beatrice,Bonomo Lorenzo,Volpe Massimo,Crea Filippo,Autore Camillo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-009-0363-x.pdf

Reference36 articles.

1. Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29(23):2909–2945

2. Fox KAA, Steg GP, Eagle KA et al (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 297(17):1892–1900

3. Biagini E, van Geuns RJ, Baks T et al (2006) Comparison between contrast echocardiography and magnetic resonance imaging to predict improvement of myocardial function after primary coronary intervention. Am J Cardiol 97(3):361–366

4. Takemura G, Nakagawa M, Kanamori H, et al (2009) Benefits of reperfusion beyond infarct size limitation. Cardiovasc Res, Feb 18 (Epub ahead of print)

5. Andreotti F, Crea F, Conti E (2004) Heart-kidney interactions in ischemic syndromes. Circulation 109(5):e31–e32

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin in cardiac disease;Journal of Cardiovascular Medicine;2013-12

2. Pharmacologic Therapy That Simulates Conditioning for Cardiac Ischemic/Reperfusion Injury;Journal of Cardiovascular Pharmacology and Therapeutics;2013-09-13

3. Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis;Intensive Care Medicine;2013-08-09

4. Serum erythropoietin: a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis among the patients with coronary chronic total occlusion;Biomarkers;2013-05-14

5. Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction;Sleep and Breathing;2013-01-23